`
`AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark
`Office
`P.O. Box 1450
`Alexandria, VA 22313−1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`(cid:16)____ Trademarks or (cid:16) X Patents. ( (cid:16)____ the patent action involves 35 U.S.C. § 292.)
`
`DOCKET NO.
`DATE FILED
`
`2:13−cv−00391−ES−SCM1/18/2013
`PLAINTIFF
`JAZZ PHARMACEUTICALS, INC.
`
`U.S. DISTRICT COURT
`NEWARK, NJ
`DEFENDANT
`AMNEAL PHARMACEUTICALS, LLC
`
`PATENT OR
`TRADEMARK NO.
`1 US 6,472,431 B2
`
`DATE OF PATENT
`OR TRADEMARK
`Oct. 29, 2002
`
`2 US 6, 780,889 B2
`
`3 US 7,262,219 B2
`
`4 US 7,851,506 B2
`
`5 US 7,895,059 B2
`
`Aug. 24, 2004
`
`Aug. 28, 2007
`
`Dec. 14, 2010
`
`*Feb. 22, 2011
`
`HOLDER OF PATENT OR TRADEMARK
`
`Orphan Medical, Inc., Minnetonka, MN (US)
`
`Orphan Medical, Inc., Minnetonka, MN (US)
`
`Orphan Medical, Inc., Minnetonka, MN (US)
`
`Jazz Pharmaceuticals, Inc., Palo Alto, CA (US)
`
`Jazz Pharmaceuticals, Inc., Palo Alto, CA (US)
`
`In the above−−entitled case, the following patent(s)/ trademark(s) have been included:
`DATE INCLUDED
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`___ Amendment ___ Answer ___ Cross Bill ___ Other Pleading
`
`1 2 3 4 5
`
`In the above−−entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
` William T. Walsh
`
`(BY) DEPUTY CLERK
` s/ LEROY DUNBAR
`
`DATE
` 1/18/2013
`
`Copy 1−−Upon initiation of action, mail this copy to Director Copy 3−−Upon termination of action, mail this copy to Director
`Copy 2−−Upon filing document adding patent(s), mail this copy to Director Copy 4−−Case file copy
`
`